Dr. Tony Coles is a prominent biopharmaceutical leader who has served as Chairman and CEO for companies like Yumanity, Cerevel Therapeutics, and Onyx Pharmaceuticals, which he led to a $10. 4 billion acquisition. A trained cardiologist with degrees from Duke, Harvard, and Johns Hopkins, he focuses on developing transformative medicines for neurodegenerative diseases and cancer.
Beyond his corporate roles, Dr. Coles is deeply committed to social and cultural causes. He co-founded the Black Economic Alliance to drive economic progress for Black Americans and serves on the boards of The Metropolitan Museum of Art and the Smithsonian National Museum of African American History and Culture.
He transitioned from being a practicing cardiologist to a biopharmaceutical executive to impact hundreds of thousands of lives at once, rather than one patient at a time.
Tony Coles
Chairman at Yumanity Therapeutics
Charleston, South Carolina, United States
Overview
Topics They Care About
Biotech Leadership
Has a distinguished career leading and scaling biopharma companies, including Onyx, Vertex, and Yumanity, with a focus on building strong corporate cultures and developing novel medicines.
Economic Empowerment
Co-founded and co-chairs the Black Economic Alliance, an organization dedicated to advancing economic progress, generational wealth, and opportunity for the Black community.
Neurodegenerative Diseases
Co-founded Yumanity Therapeutics specifically to transform drug discovery for diseases like Alzheimer's and Parkinson's, a key area of his professional focus in recent years.
Media Appearances
Yumanity Therapeutics Launched by Tony Coles, M.D. to Identify and Develop New Therapies. Featured in Fierce Biotech
Work History
Chairman at Yumanity Therapeutics
Education
Tony has no verified education history
More Information
Social Presence :
Prographics :
Exp : N/A
Location : Charleston, South Carolina, United States
Job Level : N/A
Designation : Chairman at Yumanity Therapeutics
